Valuation: Rock Creek Pharmaceuticals Inc

Market Cap 2L 1L 1L 1L 2L 1.48Cr 2L 14.87L 6L 72.4L 6L 6L 2.5Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.75Cr 1.63Cr 1.5Cr 2.82Cr 192.71Cr 2.85Cr 19Cr 7.59Cr 94Cr 7.51Cr 7.35Cr 326.1Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+2.49%+1.98%+54.22%+154.40% 1,04800Cr
+0.72%-1.28%+52.48%+47.25% 60TCr
+1.07%+4.62%+38.54%+78.17% 45TCr
+0.63%+2.08%+30.59%+21.56% 33TCr
+1.98%+2.55%+37.13%+37.55% 28TCr
+0.90%+1.04%+22.09%+15.99% 26TCr
-1.20%+1.36%-21.14%-41.57% 22TCr
+0.57%+3.09%+23.78%+55.97% 20TCr
-2.20%+0.18%+20.32%+61.56% 16TCr
Average +0.05%+1.74%+28.67%+47.87% 39.46TCr
Weighted average by Cap. -0.19%+1.69%+38.16%+73.05%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.38Cr -3.13Cr -2.88Cr -5.43Cr -370.95Cr -5.49Cr -37Cr -15Cr -181.8Cr -14Cr -14Cr -627.7Cr -68.45L -60L -55.59L -51.17L -96.48L -66Cr -97.65L -6.63Cr -2.6Cr -32Cr -2.57Cr -2.51Cr -111.55Cr
Net Debt -45T -39.44T -36.55T -33.64T -63.43T -43.34L -64.2T -4L -2L -21.24L -2L -2L -73.34L 1.99Cr 1.74Cr 1.61Cr 1.48Cr 2.8Cr 191.24Cr 2.83Cr 19Cr 7.53Cr 94Cr 7.45Cr 7.29Cr 323.6Cr
Logo Rock Creek Pharmaceuticals Inc
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-